10 August 2016
DETAILS
In the first half of 2016,
Net profit grew by 8%.
Net investments were DKK 542 million,
free cash flow before acquisitions was
DKK 1,354 million and
ROIC (incl. goodwill) was 25.4%.
EBIT was on par, and
the EBIT margin was 27.2%, also on par
with the first half of 2015.
Adjusting for the restructuring costs in Q1,
the EBIT margin would have expanded
to above 28% and
EBIT growth to around 4%
compared with the first half of 2015.
sales grew by 3% organically and
were flat in DKK compared with the first half of 2015.
Peder Holk Nielsen,
“Our business improved in the second quarter.
We delivered strong earnings, and we increased
our sales growth although we had aimed higher.
We're on track to reach our full-year profit target,
but we adjust our sales expectations due to
the performance in the second quarter
and the uncertainty facing many of our markets.
Our pipeline of sustainable biological solutions
remains strong, and we'll soon launch
exciting, new innovation in BioAg.”
WWW.CHEMWINFO.COM BY KHUN PHICHAI
